Home / Central Data Catalog / FRESH-PEF60092-EN
central

Prospective Cohort of Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer

France, 1990 - 3000
Reference ID
FRESH-PEF60092-en
Producer(s)
François;GHIRINGHELLI
Metadata
DDI/XML JSON
Study website Interactive tools
Created on
Feb 18, 2026
Last modified
Feb 18, 2026
Page views
39
  • Identification
  • Scope
  • Coverage
  • Producers and sponsors
  • Study authorization
  • Sampling
  • Survey instrument
  • Data collection
  • Study activities
  • Data Access
  • Contacts

    • Identification

    Survey ID number

    FRESH-PEF60092-en
    Title

    Prospective Cohort of Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer
    Abbreviation or Acronym

    BREAST CANCER CHEMOTHERAPY
    Country
    Name Country code
    France fr
    Kind of Data

    ['Paraclinical data (non-biological)','Paraclinical data (non-biological) : Imaging','Biological data']
    Unit of Analysis

    Individuals

    Scope

    Topics
    Topic Vocabulary
    Oncology health theme
    Malignant neoplasms of breast cim-11
    Healthcare system determinants: Use of care health determinant
    Healthcare system determinants health determinant
    Keywords
    state local recurrence metastatic histological data imaging Health episodes death treatment classification surgery

    Coverage

    Geographic Coverage

    ['Bourgogne Franche-Comté']
    Universe

    {"level_sex_clusion_I":[{"value":"Female","concept":{"vocab":"MeSH","vocabURI":"D005260"}}],"level_age_clusion_I":[{"value":"Young Adult (19 to 24 years)","concept":{"vocab":"MeSH","vocabURI":"D055815"}},{"value":"Adult (25 to 44 years)","concept":{"vocab":"MeSH","vocabURI":"D000328"}},{"value":"Middle Aged (45 to 64 years)","concept":{"vocab":"MeSH","vocabURI":"D008875"}},{"value":"Aged (65 to 79 years)","concept":{"vocab":"MeSH","vocabURI":"D000368"}}],"level_type_clusion_I":"Patients population","level_type_clusion_other":"","clusion_I":"Patients with breast cancer receiving neoadjuvant chemotherapy; - patient's written consent.","clusion_E":""}

    Producers and sponsors

    Primary investigators
    Name
    François;GHIRINGHELLI
    Producers
    Name Role
    CENTRE HOSPITALIER UNIVERSITAIRE DE DIJON sponsor
    Funding Agency/Sponsor
    Name
    CENTR GEORGES FRANCOIS LECLERC

    Study authorization

    Agency
    Agency name
    CNIL

    Sampling

    Sample frame

    Unit Type

    ['Through organizations (health services or institutions, schools, businesses, etc.)']
    Sampling Procedure

    ['{"concept":{"vocabURI":"Other","vocab":"CESSDA"},"value":"Other"}']

    Survey instrument

    Questionnaires

    Access on specific project only
    Methodology notes

    Observational Study

    Data collection

    Dates of Data Collection
    Start End
    1990-01-01 3000-01-01
    Mode of data collection
    • {"concept":{"vocabURI":"Transcription","vocab":"CESSDA"},"value":"Converting or copying information into a structured record"}

    Study activities

    Study activities
    Type
    primary evaluation
    Description
    Health event/morbidity Health event/mortality

    Data Access

    Access conditions

    Data may be used by academic teams Access for biological portion of study carried out in INSERM Unit U866 (Prof. Eric Solary, Dr. Ghiringhelli) in Dijon and INSERM Unit 645 in Besançon Data may not be used by industrial teams
    Availability Status

    {"value":"Restricted access","extLink":[{"title":"COAR","uri":"http://purl.org/coar/access_right/c_16ec"}]}
    Restrictions

    Data may be used by academic teams. Data may not be used by industrial teams

    Contacts

    Contacts
    Name Email
    François;GHIRINGHELLI francois.ghiringhelli@inserm.fr
    Back to Catalog